Last updated: January 3, 2023
Sponsor: Institut de cancérologie Strasbourg Europe
Overall Status: Active - Recruiting
Phase
N/A
Condition
Brain Metastases
Brain Tumor
Brain Cancer
Treatment
N/AClinical Study ID
NCT05464992
2022-005
2022-A00910-43
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Patients admitted to the Nuclear Medicine and Molecular Imaging department of ICANS (Institut de cancérologie strasbourg Europe) for a PET/MRI exam dedicated to:
- Preoperative evaluation of a cerebral expansion lesion
- Evaluation of glioma recurrences
- Evaluation of brain metastases
- Evaluation of recurrence of metastases
Exclusion
Exclusion Criteria:
- Contraindication to the realization of an MRI
- Minor or patients placed under guardianship or supervision
- Patients deprived of liberty
- Patients placed under judicial protection
- Patients that are not able to express their consent
- Pregnant and breastfeeding women
Study Design
Total Participants: 800
Study Start date:
December 28, 2022
Estimated Completion Date:
December 28, 2036
Study Description
Connect with a study center
France Institut de cancérologie Strasbourg Europe
Strasbourg,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.